Generic prescribing and substitution head EU industry's cross-border concerns
This article was originally published in Scrip
Executive Summary
Responses to a recent consultation on the cross-border recognition of drug prescriptions show that the matters that concern stakeholders at EU level are much the same as those that have previously dominated the policy debate at national level.